Immunogenicity and pharmacokinetic studies of recombinant Factor VIII containing lipid cochleates

Author： Kosloski Matthew P. Peng Aaron Varma Prashant R. Fathallah Anas M. Miclea Razvan D. Mager Donald E. Balu-iyer Sathy V.

Publisher： Informa Healthcare

ISSN： 1521-0464

Source： Drug Delivery, Vol.18, Iss.4, 2011-05, pp. : 246-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunogenicity of Liposomes Containing Lipid Core Peptides and the Adjuvant Quil A

By White Karen Rades Thomas Kearns Philip Toth Istvan Hook Sarah

Pharmaceutical Research, Vol. 23, Iss. 7, 2006-07 ,pp. : 1473-1481

Springer Publishing Company

Access to resources Recommend Favorite

Factor VIII Baxter: rAHF-PFM, Recombinant Anti-Haemophilic Factor Protein-Free Method, Recombinant Factor VIII Protein-Free

By Limited A.I.

Drugs in R&D, Vol. 4, Iss. 6, 2003-01 ,pp. : 366-368

Adis International

Access to resources Recommend Favorite

Solid Surface Chemical and Physical Effects on the Adsorption of Recombinant Factor VIII

By Tai Yuan-Ching McGuire Joseph Joshi Omkar Wang D. Q.

Pharmaceutical Development and Technology, Vol. 14, Iss. 1, 2009-01 ,pp. : 126-130

Informa Healthcare

Access to resources Recommend Favorite

Population pharmacokinetics of recombinant factor VIII Fc fusion protein

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 3, 2015-03 ,pp. : 163-174

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recombinant Factor VIIa (Eptacog Alfa): A Pharmacoeconomic Review of its Use in Haemophilia in Patients with Inhibitors to Clotting Factors VIII or IX

By Lyseng-Williamson Katherine A. Plosker Greg L.

PharmacoEconomics, Vol. 25, Iss. 12, 2007-01 ,pp. : 1007-1029

Adis International

Access to resources Recommend Favorite